| Name | Title | Contact Details |
|---|
Since 1997, Network Health has been committed of improving the health and well-being of its members and their diverse communities. Today the company provides high-quality, comprehensive health care coverage to more than 160,000 residents who qualify for Mass Health and Commonwealth Care in more than 300 cities and towns across Massachusetts.
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Better Nutritionals is Californias Premier Contract Manufacturer for Gummy Vitamins, Functional Supplements, and More.
Ra Pharma combines novel insights into complement and other innate immunity pathways with leadership in macrocycle technology to transform the lives of patients with life threatening disorders.
HealthRisk Resource Group is a Orange, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.